Cargando…

Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report

BACKGROUND: Metastatic colorectal cancer is one of the most common causes of cancer death worldwide. RAS and BRAF mutational analyses are strongly recommended before beginning chemotherapy in the metastatic setting for their predictive role for the efficacy of anti-EGFR monoclonal antibodies. In mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Stefano, Alfonso, Zanaletti, Nicoletta, Cassata, Antonino, Silvestro, Lucrezia, Nappi, Anna, Casaretti, Rossana, Romano, Carmela, Foschini, Francesca, Cardone, Claudia, Borrelli, Marco, Petrillo, Antonella, Budillon, Alfredo, Delrio, Paolo, Avallone, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939440/ https://www.ncbi.nlm.nih.gov/pubmed/36814823 http://dx.doi.org/10.3389/fonc.2023.1084681

Ejemplares similares

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
por: Cardone, C., et al.
Publicado: (2023)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol
por: Avallone, Antonio, et al.
Publicado: (2020)

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
por: Avallone, Antonio, et al.
Publicado: (2021)

Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting
por: Granata, Vincenza, et al.
Publicado: (2020)

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: results of the branch trial
por: Avallone, Antonio, et al.
Publicado: (2015)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

Watch and Wait Approach for Rectal Cancer Following Neoadjuvant Treatment: The Experience of a High Volume Cancer Center
por: Rega, Daniela, et al.
Publicado: (2021)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Sequential PET/CT with [(18)F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis
por: Pecori, Biagio, et al.
Publicado: (2017)

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)
por: Avallone, Antonio, et al.
Publicado: (2014)

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study
por: Avallone, A, et al.
Publicado: (2006)

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report
por: Petrillo, Mario, et al.
Publicado: (2015)

Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection
por: Costantini, Susan, et al.
Publicado: (2023)

Role of shrinkage in esophageal–gastric junction cancer
por: Leongito, Maddalena, et al.
Publicado: (2023)

Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017)

Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy
por: Rega, Daniela, et al.
Publicado: (2021)

Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer
por: Rega, Daniela, et al.
Publicado: (2016)

Assessing response to neo-adjuvant therapy in locally advanced rectal cancer using Intra-voxel Incoherent Motion modelling by DWI data and Standardized Index of Shape from DCE-MRI
por: Petrillo, Antonella, et al.
Publicado: (2018)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis
por: Rega, Daniela, et al.
Publicado: (2022)

Precision medicine in gastric cancer
por: Bonelli, Patrizia, et al.
Publicado: (2019)

Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile
por: Petrillo, Antonella, et al.
Publicado: (2016)

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome
por: Calemma, Rosa, et al.
Publicado: (2012)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)
por: Avallone, Antonio, et al.
Publicado: (2016)

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
por: Grumetti, Laura, et al.
Publicado: (2022)

Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection
por: Granata, Vincenza, et al.
Publicado: (2019)

Diffusion kurtosis imaging in patients with locally advanced rectal cancer: current status and future perspectives
por: Granata, Vincenza, et al.
Publicado: (2019)

Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
por: Rosati, Gerardo, et al.
Publicado: (2022)

Symptomatic intermittent ventricular pre-excitation in adult: a monocentric retrospective study
por: Robles, A G, et al.
Publicado: (2023)

Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
por: Sforza, Vincenzo, et al.
Publicado: (2017)

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence
por: Granata, Vincenza, et al.
Publicado: (2023)

Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver Metastases
por: Granata, Vincenza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_43qul1q2fgt7274rvu9s7lp656